Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boston Scientific invests in Intelect, gets DBS rights

Executive Summary

Boston Scientific has received a co-exclusive license to neuromodulation company Intelect Medical's Dimension software technology. Along with fellow Series B investor Greatbatch, Boston Scientific has also agreed to buy $11-13.5mm in Intelect common stock, and the two companies may buy additional equity in the future. (This financing for Intelect is considered a Series B extension.)
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies